A one-stop-shop CRO bringing together innovative platforms, strategic solutions and specialized expertise to drive drug development and advance diverse fields of research.
Policies, Terms & Conditions
Huningue, France – Firalis Molecular Precision, a fast-growing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), announces its participation in the upcoming 31st International Precision Med Tri-Con in San Diego. The event, scheduled to take place March 26-28, serves as a premier meeting ground for the diagnostics and precision medicine community.
With a focus on the latest research, technologies, and business models in implementing precision medicine, the conference will cover a wide array of topics including biomarkers, companion diagnostics, genomic medicine, precision health, and more. Discussions will also delve into innovation and market access strategies for at-home diagnostics, point-of-care testing, and molecular diagnostics for infectious diseases.
This year’s agenda promises to explore emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multi-omics in advancing precision medicine.
Firalis Molecular Precision is enthusiastic about the opportunity to connect and collaborate with fellow experts in the field. As a CRO & CDMO dedicated to providing advanced and tailored bioanalytical services, we are committed to supporting drug and diagnostic product development projects with precision and expertise.
"Our participation in the 31st International Precision Med Tri-Con underscores our commitment to driving advancements in precision medicine. We are excited to engage with the global diagnostics and precision medicine community and showcase how our tailored multi-omics services can contribute to advancing patient care and innovative research projects."
- Sébastien Langé
CEO of Firalis Molecular Precision, Inc.
Attendees are encouraged to visit FMP’s booth (327) to learn more about our comprehensive suite of bioanalytical services and to explore potential collaborations.
Find more information on the event and join us at Precision Med Tri-Con | Must-Attend Conference for the Precision Medicine Community (triconference.com)
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
With headquarters in Huningue, France, and a presence in Cambridge, MA, USA, FMP is renowned for its commitment to innovation and excellence.
Leveraging cutting-edge technologies, FMP offers a comprehensive suite of bioanalytical services encompassing biobanking, multiomics-driven analyses (including genomics, proteomics, transcriptomics, lipidomics, and metabolomics), as well as omic data analysis, assay development, and custom in vitro diagnostic (IVD) kit manufacturing.
Our mission is to empower healthcare professionals, researchers, and biopharmaceutical entities with the tools and solutions they need to make progress towards better patient care and a more personalized medicine.
Share this article on your socials